F-Term-List

A61K39/00-39/44

AA00
USES

AA01

AA02

AA03

AA04

AA05

AA06

AA07

AA08

. Use of the characteristics of specific antigens and antibodies*

. . Use of the characteristics of specific antigens*

. . . Vaccines

. . . . Vaccine mixtures or polyvalent vaccines

. . . Toxoids

. . . Medicines other than vaccines or toxoids*

. . . Affinity chromatography

. . . Internal or external examinations

AA11

AA12

AA13

AA14

AA15

AA16

AA17

AA18

AA19

. . Use of the characteristics of specific antibodies*

. . . Antitoxins and antiserums

. . . Antibodies for specific substances

. . . . Monoclonal antibodies

. . . . Anti-ideotype antibodies

. . . . Chimera combination antibodies

. . . Medicinal preparations other than antibodies, antitoxins, and antiserums*

. . . Use of the characteristics of specific antibodies for affinity chromatography

. . . Internal and external examinations

AA21

AA22

AA23

AA24

AA25

AA26

AA27

. . . Connection with other medicinal components (Missile cancer chemotherapy)

. . . . Means of connection

. . . . . Connection by means of sulfur

. . . . . Connection by means of macromolecules

. . . . Medicinal components*

. . . . . Carcinostatic substances* (i.e., chemotherapy)

. . . . . Toxins*

AA31

AA32

AA33

AA34

AA35

AA36

AA37

AA38

AA40

. Materials that do not use the specific characteristics of antibodies and antigens

. . Medicinal preparations*

. . . Immunoglobulin

. . . . Immunoglobulin derivative

. . . . Preparations containing other active components

. . . . . Histamines

. . . . . Active components containing specific antibodies for use against specific antigens

. . Adjuvants

. Others*

BA00
BACTERIAL ANTIGENS

BA01

BA02

BA03

BA04

BA05

BA06

BA07

BA08

BA09

BA10

. Antigens in general

. Protozoa antigens*

. . Trypanosoma antigens

. . Leishmania antigens

. . Coccidia antigens

. . Hemosporidia antigens

. Bacterial antigens*

. . Gram-positive bacteria*

. . . genus Mycobacterium

. . . Corynebacterium and Propionibacterium

BA11

BA12

BA13

BA14

BA15

BA16

BA17

BA18

BA19

BA20

. . . genus Lactobacillus and genus Bacillus

. . . genus Clostridium

. . . genus Staphylococcus

. . . genus Streptococcus

. . Gram-negative bacteria*

. . . genus Neisseria

. . . genus Brucella and genus Bordetella

. . . genus Pasteurella and genus Haemophilus

. . . genus Pseudomonas

. . . genus Vibrio and genus Campylobacter

BA21

BA22

BA23

BA24

BA25

BA26

BA27

. . . genus Escherichia and genus Klebsiella

. . . genus Proteus

. . . genus Yersinia

. . . genus Salmonella and genus Shigella

. . . genus Fusobacterium and genus Bacteroides

. . Actinomycete (ray fungus)

. . . genus Streptomyces

BA31

BA32

BA33

BA34

BA35

BA36

BA37

BA38

. . Structural components

. . . Envelopes

. . . . Cell walls

. . . . Cytoplasmic membranes

. . . Protoplasm

. . . Cilia

. . . Flagella

. . . Capsule

BA41

BA42

BA43

BA45

BA46

BA47

BA48

BA49

. . Enterotoxins

. . . Endotoxins

. . . Exotoxins

. Chlamydia

. Spirochaetaceae

. Rickettsiacae

. Mycoplasma

. Fungal antigens*

BA51

BA52

BA53

BA54

BA55

BA56

BA57

BA58

BA59

BA60

. Viral antigens*

. . Picornaviridae

. . . Poliovirus

. . . Foot-and-mouth disease virus

. . Orthomyxoviridae

. . Reoviridae

. . Paramyxoviridae

. . . Mumps virus or measles virus

. . . Newcastle disease virus

. . . Canine distemper virus

BA61

BA62

BA63

BA64

BA65

BA66

BA67

BA68

BA69

. . Togavirus

. . . Japanese encephalitis virus

. . . Rubella virus

. . Rhabdoviridae

. . Retrovirus

. . . Oncovirus

. . . . Leukemia virus

. . . . . Human T-cell lymphoma virus (HTLV-1)

. . . . . Human immunodeficiency virus (HIV)

BA71

BA72

BA73

BA74

BA75

BA76

BA77

BA78

BA79

BA80

. . Coronaviridae

. . . Mouse hepatitis virus

. . . Porcine transmissible gastroenteris virus

. . Arenavirus

. . Parvovirus

. . Papovavirus

. . Adenovirus

. . Herpesvirus

. . . Chicken pox or shingles virus

. . . Epstien-Barr virus

BA81

BA82

BA83

BA84

BA85

BA86

BA87

BA88

BA89

BA90

. . . Marek=s disease virus

. . . Infectious rhinotracheitis virus

. . . Cytomegalo virus

. . . Equine rhinopneumonitis virus

. . Pox virus

. . . Vaccine virus and smallpox virus

. . Hepatitis virus

. . . Type-A hepatitis virus

. . . Type-B hepatitis virus

. . . . Hepatitis B surface antigen (HBs Ag)

BA91

BA92

BA99

. . . . Hepatitis B core antigen (HBc Ag)

. . . Non-A or non-B type hepatitis virus

. Others*

BB00
HAPTEN ANTIGENS OR ANTIBODIES

BB01

BB02

BB03

BB04

BB05

BB06

BB07

BB08

BB09

. Antibodies related to tumors

. . Normal fetal antibodies

. Allergens

. . Pollen

. Snake venom

. Hormones

. . Proteins and polypeptides

. . . Human chorionic gonadotropin (HGC)

. . Phenol inductors

BB11

BB12

BB13

BB14

BB15

BB16

BB17

BB18

. Proteins and polypeptides*

. . Glycoproteins

. . Lipoproteins

. . Plasma proteins

. . Albumen

. . Blood coagulants and lectin

. . Cytokines

. . . Lymphokines

BB21

BB22

BB23

BB24

. Glycolipids

. Enzymes

. Nuclei

. Haptens, sugars, vitamins, coenzymes, and polysaccharides

BB31

BB33

BB34

BB35

BB36

BB37

. Immunoglobulin*

. . Immunoglobulin A (IgA)

. . Immunoglobulin D (IgD)

. . Immunoglobulin E (IgE)

. . Immunoglobulin G (IgG)

. . Immunoglobulin M (IgM)

BB41

BB42

BB43

BB44

BB50

. . Monovalent antigen-binding fragments (FaB)

. . Carbohydrate-containing fragments (Fc)

. . Bi-valent antigen-binding fragments (F(ab=)2)

. . Variants without an Fc structure

. Others*

CC00
MATERIALS

CC01

CC02

CC03

CC04

CC05

CC07

CC08

. Cells*

. . Hybridoma cells

. . Human cells

. . Cells from livestock

. . Cells from animals other than livestock

. Bacteria

. Viruses

CC11

CC12

CC13

CC14

CC15

CC16

CC17

. Bodily fluids

. . Blood

. . . Blood serum

. . . Blood plasma

. . Urine

. . Milk

. . Gastric juices

CC21

CC22

CC23

CC24

CC26

CC27

CC28

CC29

. Proteins

. . Immunoglobulins

. . . Monoclonal antibodies

. . Toxins

. Structures

. . Placentas

. . Brains

. . Internal organs

CC31

CC32

CC33

CC40

. Chemical compounds

. . Peptides

. . Saccharides

. Others*

DD00
PREPARATION METHODS

DD01

DD02

DD03

DD04

DD05

DD06

DD07

DD08

DD09

DD10

. Deactivation

. . Deactivating agents*

. . . Formalin

. . Potentially mutagenic pharmaca*

. . . Nitrosoguanidine

. . Subculturing or cell passage

. . Physical processing

. . . Heating

. . . Dilution

. . . Irradiation with infrared

DD11

DD12

DD13

DD14

DD15

DD16

DD17

DD18

. Stabilization

. . Stabilization with regards to heat

. . . Stabilizing agents

. . . . Saccharides

. . . . Amino acids

. . . . Proteins

. . Stabilization regards to oxygen

. . Stabilization regards to microbes

DD21

DD22

DD23

DD24

DD25

DD26

. Culture

. . In vivo

. . In vitro

. . . Culture media*

. . . Temperature*

. . . pH*

DD31

DD32

DD33

DD34

DD35

DD36

DD37

DD38

DD39

DD40

. Purification

. . Chromatography

. . . Affinity chromatography

. . . Ion-exchange chromatography

. . . Gel-filtration chromatography

. . . Adsorption chromatography

. . Precipitation or separation by using chemicals*

. . . Processing by salting-out or by inorganic salts

. . . Processing by inorganic solutions

. . . Processing by water-soluble macromolecules

DD41

DD42

DD43

. . Dialysis or ultrafiltration

. . Density-gradient centrifuging

. . Electrophoresis

DD51

DD52

DD53

DD54

DD55

DD56

DD57

DD58

DD59

. Chemical processing

. . Bridge-formation reactions*

. . . Bridge formation from -SH to -SH

. . . Bridge formation from -SH to -NH2

. . . Bridge formation from -NH2 to -NH2

. . . Bridge formation from -NH2 to -COOH

. . Oxidation

. . Reduction

. . Modification of functional groups

DD61

DD62

DD63

. Cloning

. . Gene-switching

. . Cellular fusion

DD71

DD72

DD73

DD74

DD75

. Separation

. . Supported separation

. . . Polysaccharides

. . . Synthetic resins

. . . Inorganic materials

DD81

DD84

DD86

DD88

DD90

. Enzyme processing

. Freeze-drying

. Addition of an adjuvant

. Immunization

. Others*

EE00
COMPONENTS

EE01

EE03

EE05

EE06

EE07

EE10

. Single components (active components)

. Multiple components (active components)

. Inclusion of inactive components

. . Adjuvant

. . Stabilizing agents

. Others*

FF00
ADJUVANTS

FF01

FF02

FF03

. Inorganic compounds*

. . Aluminum hydroxide

. . Freund's complete adjuvant (FCA)

FF11

FF12

FF13

FF14

FF16

FF17

FF18

FF19

FF20

. Organic compounds

. . Chemical structures*

. . . Peptides and proteins

. . . Saccharides (e.g., sugars, glycoproteins, and glycolipids)

. . Origins or sources

. . . Synthetic origins or sources

. . . Natural origins or sources*

. . . . Microbes*

. . . . . Tuberculosis bacteria (i.e., Freund's complete adjuvant [FCA])

FF21

FF24

FF30

. Materials of unknown chemical structure

. Adjuvants with limitations on their components

. Others*

GG00
APPLICATIONS

GG01

GG02

GG03

GG04

GG05

GG06

GG08

GG10

. Injections*

. . Venous injections (including intravenous drips)

. . Intramuscular injections

. . Hypodermic injections

. . Intradermal injections

. . Injections in the abdominal cavity

. Oral

. Others*

A61K49/00-49/22;50/00;50/00,200;51/00;51/00,200;51/02;51/02,200;51/04;51/04,200-51/04,300;51/04,320-51/06;51/06,200-51/08;51/08,200-51/10;51/10,200-51/12;51/12,200

HH00
DIAGNOSTIC APPLICATIONS

HH01

HH03

HH05

HH07

HH09

. Contrast media

. . Radiation

. . X-rays

. . Nuclear magnetic resonance (NMR)

. . Ultrasound

HH11

HH13

HH15

HH17

HH20

. Fluorescent agents

. Coloring agents

. Allergy-inducing agents

. Processing agents for use before detection procedures

. Others*

JJ00
FORMS

JJ01

JJ02

JJ03

JJ05

JJ08

. Liquids

. . Solutions

. . Suspended solutions and emulsions

. . . Liposomes

. . Foaming bodies

JJ11

JJ12

JJ16

JJ17

JJ20

. Solids

. . Pastes

. Gases

. . Aerosols

. Others

KA00
COMPONENTS WITH SPECIFIC FUNCTION

KA01

KA03

KA04

KA05

KA07

KA08

KA09

KA10

. Antigens*

. Antibodies

. . Monoclonal antibodies

. . Chimera antibodies

. Complex components

. . Inorganic ligands

. . Organic ligands

. . . Sugar ligands

KA11

KA14

KA16

KA17

KA18

KA19

KA20

. . . Protein ligands

. Foaming agents

. Surfactants, emulsifiers, and break-down agents

. . Anionic agents

. . Amphoionic agents

. . Cationic agents

. . Nonionic agents

KA22

KA23

KA24

KA26

KA27

KA28

KA29

KA30

. Viscosity-adjustment agents

. . Thickeners

. . Viscosity-reducing agents

. Label

. . Fluorescent labels

. . Magnetic labels

. . Radioactive isotope labels

. . Stable isotope labels

KA32

KA34

KA36

KA37

KA40

. Stabilizing agents

. Reduction agents

. Medicines or drugs

. . Antibiotics

. Others

KB00
COMPONENTS COMPOSED OF SPECIFIC SUBSTANCES

KB01

KB02

KB03

KB05

KB07

KB08

KB09

KB10

. Inorganic compounds

. . Inorganic compounds containing specific elements

. . . Alkali metals

. . . Alkaline earth metals, Beryllium (Be), and Magnesium (Mg)

. . . Elements from groups IIIA - VIIA, VIII, IB, or IIB on the periodic table

. . . . Iron (Fe)

. . . . Technetium (Tc)

. . . . Rhenium (Re)

KB11

KB12

KB15

KB17

KB18

KB19

KB20

. . . . Scandium (Sc) and Yttrium (Y)

. . . . Lanthanides

. . . Elements from group 3B on the periodic table

. . . Halogen

. . . . Iodine (I)

. . . . Bromine (Br)

. . . . Fluorine (F)

KB21

KB23

KB24

KB25

KB26

KB28

KB29

KB30

. . . Noble gases

. . Inorganic acids and inorganic acid salts

. . . Carbonic acid or carbonate

. . . Sulfuric acid, sulfites, and salts thereof

. . . . Barium sulfate

. . Oxides and peroxides

. . Hydroxides

. . Halogen compounds

KB31

KB32

KB33

KB34

KB37

KB38

KB39

. . Sulfides

. . Ammonia and ammonium

. . Cyanide compounds

. . Inorganic materials of natural origin

. Organic compounds

. . Hydrocarbons

. . Halogen-containing compounds

KB41

KB42

KB44

KB45

KB46

KB47

KB48

KB49

KB50

. . Oxygen-containing compounds

. . . Carboxylic acid and salts thereof, acid anhydrides, and esters

. . Nitrogen-containing compounds

. . . Amines

. . . Carboxylic acid amides

. . . . Halogenated benzoic acid amides

. . . . Halogenated phthalic acid amides

. . . Carbamic acids or urea derivatives

. . . Oximes

KB52

KB54

KB55

KB56

KB57

KB59

KB60

. . Sulfur-containing compounds

. . Complex cyclic compounds or heterocyclic compounds

. . . Compounds containing oxygen in the rings

. . . Compounds containing nitrogen in the rings

. . . Compounds containing sulfur in the rings

. . Phosphorus-containing compounds

. . . Phospholipids

KB61

KB63

KB65

KB67

KB68

KB69

KB70

. . Silicon-containing compounds

. . Prostaglandins

. . Steroids

. Macromolecules

. . Macromolecules obtained from reactions only affecting carbon-to-carbon (C=C) bonds

. . . Only carbon and hydrogen or only carbon, hydrogen and halogen

. . . Unsaturated monocarbonic acids

KB72

KB73

KB74

KB75

KB76

KB78

KB79

KB80

. . Macromolecules obtained from reactions other than those affecting with carbon-to-carbon (C=C) bonds

. . . Isocyanates and polyurethanes

. . . Polyethers and polythioethers

. . . Polyesters

. . . Polyamides

. Sugars

. . Polysaccharides

. . . Dextrose

KB82

KB83

KB85

KB86

KB87

KB88

. Protein peptides

. . Blood-plasma proteins

. . Myosin

. . 2,4,7 trinitrofluorenone (TNF)

. . Interferon

. . Interleukins

KB91

KB92

KB93

KB95

KB97

KB99

. Nucleotides, nucleosides, and nucleic acids

. . Nucleic acids

. Fats, oils and waxes

. Hormones

. Vitamins

. Others*

LL00
DIAGNOSTIC AREAS

LL01

LL03

LL05

LL07

LL09

. Vascular system

. Lymphatic system

. Digestive system

. Circulatory system and hematopoietic system

. Respiratory system

LL11

LL12

LL13

LL15

LL17

LL18

LL20

. Excretory system

. Reproductive system

. Central nervous system

. Endocrine system

. Locomotor system

. Cancer or cancerous areas

. Others*

4C085	MEDICINES CONTAINING ANTIBODIES OR ANTIGENS FOR USE AS INTERNAL DIAGNOSTIC AGENTS
	A61K39/00 -39/44;49/00-50/00;50/00,200-51/00;51/00,200-51/02;51/02,200-51/04;51/04,200-51/04,300;51/04,320-51/06;51/06,200-51/08;51/08,200-51/10;51/10,200-51/12;51/12,200